Astrana Health (NASDAQ:ASTH) Price Target Lowered to $56.00 at Stifel Nicolaus

Astrana Health (NASDAQ:ASTH) had its target price reduced by equities researchers at Stifel Nicolaus from $70.00 to $56.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ target price points to a potential upside of 44.67% from the stock’s previous close.

A number of other brokerages also recently issued reports on ASTH. Robert W. Baird lifted their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a report on Monday, December 16th. Finally, Truist Financial decreased their price target on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $63.00.

Astrana Health Stock Down 1.0 %

NASDAQ:ASTH traded down $0.38 during midday trading on Thursday, reaching $38.71. The company had a trading volume of 66,395 shares, compared to its average volume of 332,231. The firm has a market capitalization of $2.18 billion, a price-to-earnings ratio of 29.78, a PEG ratio of 1.50 and a beta of 1.20. The stock’s fifty day simple moving average is $35.11 and its 200-day simple moving average is $45.12. Astrana Health has a 12-month low of $29.08 and a 12-month high of $63.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC acquired a new position in Astrana Health in the 3rd quarter valued at about $35,000. KBC Group NV acquired a new position in Astrana Health in the 3rd quarter valued at about $70,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Astrana Health during the 4th quarter worth approximately $40,000. Quarry LP acquired a new position in Astrana Health during the 3rd quarter worth approximately $77,000. Finally, Quest Partners LLC acquired a new position in Astrana Health during the 3rd quarter worth approximately $133,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.